Immunic to Participate in Investor and Scientific Conferences in February
Press Releases
February 4, 2025

Immunic to Participate in Investor and Scientific Conferences in February

NEW YORK, Feb. 4, 2025 /PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases,

bradford

The Bradford Era

Local & Social